Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci U S A. 1990;87:6934–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taniguchi T, Matsui H, Fujita T, Takaoka C, Kashima N, Yoshimoto R, et al. Structure and expression of a cloned cDNA for human interleukin-2. Nature. 1983;302:305–10.

Article  CAS  PubMed  Google Scholar 

Leonard WJ, Depper JM, Crabtree GR, Rudikoff S, Pumphrey J, Robb RJ, et al. Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature. 1984;311:626–31.

Article  CAS  PubMed  Google Scholar 

Saxton RA, Glassman CR, Garcia KC. Emerging principles of cytokine pharmacology and therapeutics. Nat Rev Drug Discov. 2023;22:21–37.

Article  CAS  PubMed  Google Scholar 

Morgan DA, Ruscetti FW, Gallo R. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science. 1976;193:1007–8.

Article  CAS  PubMed  Google Scholar 

Paliard X, de Waal MR, Yssel H, Blanchard D, Chrétien I, Abrams J, et al. Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones. J Immunol. 1988;141:849–55.

Article  CAS  PubMed  Google Scholar 

Setoguchi R, Hori S, Takahashi T, Sakaguchi S. Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med. 2005;201:723–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yui MA, Sharp LL, Havran WL, Rothenberg EV. Preferential activation of an IL-2 regulatory sequence transgene in TCRγδ and NKT cells: subset-specific differences in IL-2 regulation. J Immunol. 2004;172:4691–9.

Article  CAS  PubMed  Google Scholar 

Granucci F, Vizzardelli C, Pavelka N, Feau S, Persico M, Virzi E, et al. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat Immunol. 2001;2:882–8.

Article  CAS  PubMed  Google Scholar 

Hershko AY, Suzuki R, Charles N, Alvarez-Errico D, Sargent JL, Laurence A, et al. Mast cell interleukin-2 production contributes to suppression of chronic allergic dermatitis. Immunity. 2011;35:562–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boyman O, Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol. 2012;12:180–90.

Article  CAS  PubMed  Google Scholar 

Liao W, Lin J-X, Leonard WJ. Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity. 2013;38:13–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fyfe G, Fisher RI, Rosenberg SA, Sznol M, Parkinson DR, Louie AC. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy. JCO. 1995;13:688–96.

Article  CAS  Google Scholar 

Atkins MB, Lotze MT, Dutcher JP, Fisher RI, Weiss G, Margolin K, et al. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. JCO. 1999;17:2105–2105.

Article  CAS  Google Scholar 

Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 1993;75:253–61.

Article  CAS  PubMed  Google Scholar 

Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity. 1995;3:521–30.

Article  CAS  PubMed  Google Scholar 

Suzuki H, Kündig TM, Furlonger C, Wakeham A, Timms E, Matsuyama T, et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science. 1995;268:1472–6.

Article  CAS  PubMed  Google Scholar 

Malek TR, Yu A, Vincek V, Scibelli P, Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice. Immunity. 2002;17:167–78.

Article  CAS  PubMed  Google Scholar 

Wang X, Rickert M, Garcia KC. Structure of the quaternary complex of interleukin-2 with its α, ß, and γc receptors. Science. 2005;310:1159–63.

Article  CAS  PubMed  Google Scholar 

Wang HM, Smith KA. The interleukin 2 receptor: functional consequences of its bimolecular structure. J Exp Med. 1987;166:1055–69.

Article  CAS  PubMed  Google Scholar 

Rickert M, Boulanger MJ, Goriatcheva N, Garcia KC. Compensatory energetic mechanisms mediating the assembly of signaling complexes between interleukin-2 and its α, β, and γc receptors. J Mol Biol. 2004;339:1115–28.

Article  CAS  PubMed  Google Scholar 

Levin AM, Bates DL, Ring AM, Krieg C, Lin JT, Su L, et al. Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine.’ Nature. 2012;484:529–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol. 2005;6:1142–51.

Article  CAS  PubMed  Google Scholar 

Josefowicz SZ, Lu L-F, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012;30:531–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Malek TR, Bayer AL. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol. 2004;4:665–74.

Article  CAS  PubMed  Google Scholar 

Cheng G, Yu A, Malek TR. T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells. Immunol Rev. 2011;241:63–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi H, Liu C, Tan H, Li Y, Nguyen T-LM, Dhungana Y, et al. Hippo kinases Mst1 and Mst2 sense and amplify IL-2R-STAT5 signaling in regulatory T cells to establish stable regulatory activity. Immunity. 2018;49:899-914.e6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25high regulatory cells in human peripheral blood. J Immunol. 2001;167:1245–53.

Article  CAS  PubMed  Google Scholar 

Höfer T, Krichevsky O, Altan-Bonnet G. Competition for IL-2 between regulatory and effector T cells to chisel immune responses. Front Immun. 2012;3:106–14.

Schmidt A, Oberle N, Krammer PH. Molecular mechanisms of Treg-mediated T cell suppression. Front Immun. 2012;3;46–59.

Nagasawa M, Spits H, Ros XR. Innate lymphoid cells (ILCs): cytokine hubs regulating immunity and tissue homeostasis. Cold Spring Harb Perspect Biol. 2018;10: a030304.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Silvennoinen O. Signaling Through the Hematopoietic Cytokine Receptors. Annu Rev Immunol. 1995;13:369–98.

Article  CAS  PubMed  Google Scholar 

Malek TR. The biology of interleukin-2. Annu Rev Immunol. 2008;26:453–79.

Article  CAS  PubMed  Google Scholar 

Gotthardt D, Trifinopoulos J, Sexl V, Putz EM. JAK/STAT cytokine signaling at the crossroad of NK cell development and maturation. Front Immunol. 2019;10:2590.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeiser R, Negrin RS. Interleukin-2 receptor downstream events in regulatory T cells: Implications for the choice of immunosuppressive drug therapy. Cell Cycle. 2008;7:458–62.

Article  CAS  PubMed  Google Scholar 

Liao W, Lin J-X, Leonard WJ. IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr Opin Immunol. 2011;23:598–604.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Siegel JP, Sharon M, Smith PL, Leonard WJ. The IL-2 receptor β chain (p70): role in mediating signals for LAK, NK, and proliferative activities. Science. 1987;238:75–8.

Article  CAS  PubMed  Google Scholar